deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03471078

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Randomized, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Active Non-Hematological Cancers

Sponsor: Sobi, Inc.

Conditions Chemotherapy-induced Thrombocytopenia
Interventions Avatrombopag Placebo Oral Tablet
Updated 25 times since 2018 Last updated: Sep 19, 2023 Started: Oct 12, 2018 Primary completion: Aug 28, 2020 Completion: Jan 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Chemotherapy-induced Thrombocytopenia and is currently completed. Sobi, Inc. leads this study, which shows 25 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Feb 2019 · 3 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Jul 2019 · 2 months · monthly snapshot~Jul 2019 – ~Feb 2020 · 7 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Aug 2020 · 2 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Dec 2021 · 9 months · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~May 2023 · 12 months · monthly snapshot~May 2023 – ~Oct 2023 · 5 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

25 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Oct 2023 — Jul 2024 [monthly]

    Completed PHASE3

  5. May 2023 — Oct 2023 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

▶ Show 20 earlier versions

  1. May 2022 — May 2023 [monthly]

    Active Not Recruiting PHASE3

  2. Dec 2021 — May 2022 [monthly]

    Active Not Recruiting PHASE3

  3. Mar 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE3

  4. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting PHASE3

  5. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  6. Aug 2020 — Nov 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  7. Jun 2020 — Aug 2020 [monthly]

    Recruiting PHASE3

  8. May 2020 — Jun 2020 [monthly]

    Recruiting PHASE3

  9. Mar 2020 — May 2020 [monthly]

    Recruiting PHASE3

  10. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE3

  11. Jul 2019 — Feb 2020 [monthly]

    Recruiting PHASE3

  12. May 2019 — Jul 2019 [monthly]

    Recruiting PHASE3

  13. Mar 2019 — May 2019 [monthly]

    Recruiting PHASE3

  14. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE3

  15. Nov 2018 — Feb 2019 [monthly]

    Recruiting PHASE3

  16. Sep 2018 — Nov 2018 [monthly]

    Recruiting PHASE3

  17. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE3

  18. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  19. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE3

  20. Apr 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sobi, Inc.
Data source: Sobi, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anaheim, United States , Arkhangelsk, Russia , Ashland, United States , Augusta, United States , Bakersfield, United States , Belgrade, Serbia , Bloomington, United States , Boston, United States , Budapest, Hungary , Canton, United States and 44 more locations